Serum aldosterone is associated with mortality and re-hospitalization in patients with reduced ejection fraction hospitalized for acute heart failure: analysis from the EVEREST trial-Reference-Cited by-同舟云学术

Serum aldosterone is associated with mortality and re-hospitalization in patients with reduced ejection fraction hospitalized for acute heart failure: analysis from the EVEREST trial

Published:2013-11 Issue:11 Volume:15 Page:1228-1235
ISSN:1388-9842
Container-title:European Journal of Heart Failure
language:en
Short-container-title:European Journal of Heart Failure

Author:

Girerd Nicolas¹,Pang Peter S.²³,Swedberg Karl⁴,Fought Angela⁵,Kwasny Mary J.⁶,Subacius Haris⁷,Konstam Marvin A.⁷,Maggioni Aldo⁸,Gheorghiade Mihai²,Zannad Faiez¹,

Affiliation:

1. INSERM, Centre d'Investigations Cliniques 9501, Université de Lorraine, CHU de Nancy, Institut Lorrain du cœur et des vaisseaux; Nancy France

2. Center for Cardiovascular Innovation, Northwestern University Feinberg School of Medicine; Chicago IL USA

3. Department of Emergency Medicine; Northwestern University Feinberg School of Medicine; Chicago IL USA

4. Department of Cardiology; Goteborg University; Goteborg Sweden

5. Department of Preventive Medicine; Northwestern University Feinberg School of Medicine; Chicago IL USA

6. Division of Cardiology, Department of Medicine; Northwestern University Feinberg School of Medicine; Chicago IL USA

7. The Cardiovascular Center, Tufts Medical Center, and Division of Cardiology; Tufts University School of Medicine; Boston MA USA

8. Associazione Nazionale Medici Cardiologi, Ospedalieri Research Center; Florence Italy

Publisher

Wiley

Subject

Cardiology and Cardiovascular Medicine

Reference30 articles.

1. Heart disease and stroke statistics-2009 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee;Lloyd-Jones;Circulation,2009

2. Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction;Pitt;N Engl J Med,2003

3. Randomized aldactone evaluation study investigators;Pitt;N Engl J Med,1999

4. Eplerenone in patients with systolic heart failure and mild symptoms;Zannad;N Engl J Med,2011

5. Association between performance measures and clinical outcomes for patients hospitalized with heart failure;Fonarow;JAMA,2007

Cited by 53 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Diuretic Combination Therapy in Acute Heart Failure: An Updated Review;Current Pharmaceutical Design;2024-09

2. Aldosterone Effect on Cardiac Structure and Function;Current Cardiology Reviews;2024-07

3. When to use spironolactone, eplerenone or finerenone in the spectrum of cardiorenal diseases;Nephrology Dialysis Transplantation;2024-01-08

4. An overview of mineralocorticoid receptor antagonists as a treatment option for patients with heart failure: the current state-of-the-art and future outlook;Expert Opinion on Pharmacotherapy;2022-10-13

5. Modeling heart failure with preserved ejection fraction in rodents: Where do we stand?;Frontiers in Drug Discovery;2022-08-11